GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (LTS:0EE0) » Definitions » Common Stock

uniQure NV (LTS:0EE0) Common Stock : $2.95 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is uniQure NV Common Stock?

uniQure NV's quarterly common stock increased from Jun. 2024 ($2.93 Mil) to Sep. 2024 ($2.93 Mil) and increased from Sep. 2024 ($2.93 Mil) to Dec. 2024 ($2.95 Mil).

uniQure NV's annual common stock increased from Dec. 2022 ($2.84 Mil) to Dec. 2023 ($2.88 Mil) and increased from Dec. 2023 ($2.88 Mil) to Dec. 2024 ($2.95 Mil).


uniQure NV Common Stock Historical Data

The historical data trend for uniQure NV's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

uniQure NV Common Stock Chart

uniQure NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.71 2.80 2.84 2.88 2.95

uniQure NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.88 2.92 2.93 2.93 2.95

uniQure NV Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


uniQure NV Business Description

Traded in Other Exchanges
Address
Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

uniQure NV Headlines

No Headlines